🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Influence of Cemented Cephalic Augmentation on the Outcome of Intramedullary Nailing in Pertrochanteric Hip Fractures

RecruitingNAAges 75 Years - anyAllDiego Matías Domínguez Prado
NCT06634290 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if small modifications in the surgical technique for the treatment of some kind of hip fractures, improve the result of the surgery. This small modification includes the addition of surgical bone cement to part of the intramedullary nail used in the surgery, to find out if it provides more stability to the construct and represents an improvement in the surgery result. The main question it aims to answer is: Does the addition of bone cement produces a decrease in complications related to mechanical failure of the implant used in the surgery and a decrease in the need for re-operation? Researchers will compare adding this bone cement to the standard surgical technique without it. Patients will: * Be randomly assigned to a group that will have surgery following standard protocol or to a group that will have surgery following standard protocol

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 75 years of age or older. * Diagnosis with a pertrochanteric fragility fracture. * Informed consent for participation in the study. Exclusion Criteria: * Not meeting the inclusion criteria described above. * Refusal of the patient or his/her legal representative to participate in the study. * Diagnosis with hip fracture of subtypes other than 31A1, 31A2, 31A3 and 31B3 of AO-OTA classification. * Bilateral hip fractures in the same episode. * Suffering from previous medical pathologies or comorbidities that contraindicate surgical intervention and indicate conservative management of the fracture. * Performing a surgical technique different from intramedullary nailing or using a surgical implant different from that used in the present study.
💊

What it tests

  • intramedullary nailing augmentation
  • intramedullary nailing
📍

Where

6 sites
Hospital de Monforte de Lemos
Monforte de Lemos, Spain
Hospital de Verin
Verín, Spain
Complexo Hospitalario Universitario de Vigo
Vigo, Spain
Hospital do Salnes
Vilagarcía de Arousa, Spain
Complexo Hospitalario Universitario de Ourense
Ourense, Spain
Complexo Hospitalario Pontevedra
Pontevedra, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy